Mind Cure Health Inc.

CSE: MCUR, FFT: 6MH

Company Logo

Company Overview

Mind Cure Health Inc. is a mental health and wellness company with a mission to identify and develop products that ease suffering, increase productivity and enhance mental health.

The company’s 5 Spheres framework includes:

  • Clinical Research Technology: The company anticipates acquiring diagnostic technologies for use in clinical trials and data collection tools to help clinicians receive patient feedback to improve treatment efficacy.
  • Nootropic Formulations: The company is developing nootropic, psychoactive products and substances to promote productivity and enhanced mental health, including products launched under its MoonBeam Mushroom brand.
  • Clinical Research: The company intends to evaluate the potential for clinical trials that would benefit mental health and wellness under Health Canada’s industry-leading framework for psychedelic medicines.
  • Product Discovery: The company is evaluating the legal and commercial viability of psychedelic compounds such as psilocybin, as well as new and improved psychedelic-inspired candidates, such as non-psychoactive analogs.
  • Formulations & Supply: The company is evaluating a path to manufacture, import and supply traditional and novel pharmaceutical agents for North America to satisfy the underserved access to psychoactive compounds APIs for research.

Financial Highlights

$0

Revenue (ttm)

$0

Gross Profit (ttm)

-$0.06

Diluted EPS (ttm)

Management Team

Ms. Kelsey Leigh Ramsden
Pres, CEO & Director

Mr. Michael Andrew Wolfe M.B.A., MBA, CPA, CA
Chief Financial Officer

Mr. Tarik Lebbadi
Chief Operating Officer

Mr. Geoff Belair
Chief Technology Officer

Dr. Joel Raskin
Chief Medical Officer

Mr. Daniel Herrera
VP Of Growth And Strategic Partnerships

Sign Up for Alerts

Receive an email alert every time a company announces a merger, capital raise or files for an IPO.

Company Profile

Website

Twitter

Presentation

Key Highlights

Market Capitalization
$15,081,813

Shares Outstanding
45,220,000

Shares Short (% of Float)
58,271 (0%)

Insider Ownership
5%